Basics Anika Therapeutics Inc. Anika Therapeutics Inc develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. IPO Date: January 3, 1994 Sector: Healthcare Industry: Biotech Market Cap: $128.9M Activated in VL: True Average Daily Range Avg Daily Range: $0.43 | 1.98% Avg Daily Range (30 D): $0.31 | 3.33% Avg Daily Range (90 D): $0.28 | 2.65% Institutional Daily Volume Avg Daily Volume: .1M Avg Daily Volume (30 D): .12M Avg Daily Volume (90 D): .08M Trade Size Avg Trade Size (Sh.): 100 Avg Trade Size (Sh.) (30 D): 60 Avg Trade Size (Sh.) (90 D): 59 Institutional Trades Total Inst.Trades: 1,259 Avg Inst. Trade: $1.25M Avg Inst. Trade (30 D): $1.1M Avg Inst. Trade (90 D): $.95M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.19M Avg Closing Trade (30 D): $.67M Avg Closing Trade (90 D): $.67M Avg Closing Volume: 33.19K     News Sep 5, 2025 @ 9:00 AM Anika Reports Inducement Grants Under Nasdaq Listi... Source: Anika Therapeutics, Inc. Aug 17, 2025 @ 3:00 PM INVESTOR ALERT: Pomerantz Law Firm Investigates Cl... Source: Danielle Peyton Aug 12, 2025 @ 11:34 PM ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. Co... Source: Bragar Eagel & Squire, P.C. Aug 4, 2025 @ 11:05 PM ANIKA INVESTIGATION ALERT: Bragar Eagel & Squire, ... Source: Bragar Eagel & Squire, P.C. Aug 1, 2025 @ 8:42 PM Kirby McInerney LLP Announces Investigation Agains... Source: Thomas W. Elrod Financials   TTM Q2 2025 Q1 2025 Basic EPS $-4.14 $-.28 $-.34 Diluted EPS $-4.14 $-.28 $-.34 Revenue $ 91.85M $ 28.22M $ 26.17M Gross Profit $ 53.05M $ 14.36M $ 14.68M Net Income / Loss $ -60.63M $ -3.97M $ -4.87M Operating Income / Loss $ -8.66M $ -4.18M $ -4.28M Cost of Revenue $ 38.8M $ 13.86M $ 11.49M Net Cash Flow $ -10.32M $ -.55M $ -3.9M PE Ratio